EIIP/AQVN Technologies & invention disclosures of the Biomed Protection Team members

 

• Veljkovic V. POTENT AND SELECTIVE INHIBITORS OF NAV1.7. 18526.0002USP1, 29/09/2020.
   
• Veljkovic V., Paessler S. UNIVERSAL INFLUENZA VACCINE TARGETING VIRUS/HOST RECOGNITION. WO2018144903, US20190351046, 02/02/2018.
   
• Paessler S., Veljkovic V. VACCINE WITH REDUCED ENHANCEMENT OF VIRAL INFECTION. US20170312354A1, 20/02/2017.
   
• Veljkovic V., Prljic J., Veljkovic N., Metlas R. NUCLEOTIDE SEQUENCE FOR DETECTION AND CHARACTERIZATION OF THE HIV-1 FIELD ISOLATES PARTICIPATING IN THE RECOMBINATION PROCESSES DIRECTED BY THE CHI SEQUENCE. EP01043407A3, 10/18/2000.
   
• Veljkovic V., Metlas R., Markovic D. POLYPEPTIDES MIMICKING THE ACTIVITY OF HUMAN ERYTHROPOIETIN. EP00928292A1, WO09749729A1, CA02258871AA, AU03435397A1, 07/14/1999.
   
• Veljkovic V., Metlas R., Markovic D. POLYPEPTIDER SOM ETTERAPER AKTIVITETEN TIL HUMANT ERYTROPOIETIN. NO00985993A, 02/24/1999.
   
• Veljkovic V., Metlas R. POLYPEPTIDES INVOLVED IN THE INTERACTION OF HIV GP120 WITH THE FUSIN, AND THE CC-CKR-5 CO-RECEPTORS THEREOF. GB02319252A, 05/20/1998
   
• Veljkovic V., Metlas R. PEPTIDES WHICH REACT WITH ANTIBOBY REPRESENTING THE PROGNOSTIC MARKER FOR HIV DISEASE PROGRESSION. EP00808846A3, GR98300031T1, CA02205077AA, JP10237100A2, 08/26/1998
   
• Veljkovic V., Metlas R. PEPTIDE, DIE MIT ANTIKOERPERN REAGIEREN, DIE DEN FORTSCHRITT DER HIV-ERKRANKUNG MARKIEREN. EP00808846TD, 06/25/1998.
   
• Veljkovic V., Metlas R. PEPTIDOS QUE REACCIONAN CON ANTICUERPOS QUE REPRESENTAN EL MARCADOR DE PRONOSTICO DE LA PROGRESION DE LA ENFERMEDAD DEL SIDA. ES02113333T1, 05/01/1998
   
• Veljkovic V., Prljic J., Veljkovic N., Metlas R. SEQUENZA NUCLEOTIDICA PER LA RIVELAZIONE E CARATTERIZZAZIONE DI ISOLATI OSPEDALIERI DI HIV-1 CHE PARTECIPANO NEI PROCESSI DI RECOMBINATIONI. ITMI980776A0, 04/10/1998